Yola Moride

6.6k total citations · 3 hit papers
111 papers, 4.8k citations indexed

About

Yola Moride is a scholar working on Economics and Econometrics, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Yola Moride has authored 111 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Economics and Econometrics, 19 papers in Psychiatry and Mental health and 17 papers in Pharmacology. Recurrent topics in Yola Moride's work include Health Systems, Economic Evaluations, Quality of Life (15 papers), Pharmaceutical Practices and Patient Outcomes (15 papers) and Pharmacovigilance and Adverse Drug Reactions (15 papers). Yola Moride is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (15 papers), Pharmaceutical Practices and Patient Outcomes (15 papers) and Pharmacovigilance and Adverse Drug Reactions (15 papers). Yola Moride collaborates with scholars based in Canada, France and United States. Yola Moride's co-authors include Bernard Bégaud, Christina Wolfson, Anne Perrault, Bernard Bégaud, Thiérry Ducruet, Jacques Bénichou, Lucien Abenhaim, Marie Tournier, Xavier Kurz and Ana Alvarez-Requejo and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yola Moride

109 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension

1996 813 citations Lucien Abenhaim, Yola Moride et al. New England Journal of Medicine profile →
Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

1996 614 citations Yola Moride et al. profile →
Benzodiazepine use and risk of Alzheimer's disease: case-control study

2014 380 citations Sophie Billioti de Gage, Yola Moride et al. BMJ profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yola Moride Canada	30	1.1k	785	683	610	571	111	4.8k
Bernard Bégaud France	34	1.1k 1.1×	1.3k 1.6×	902 1.3×	690 1.1×	1.1k 1.9×	179	6.8k
Ron M. C. Herings Netherlands	47	1.1k 1.0×	803 1.0×	1.2k 1.7×	1.0k 1.7×	1.5k 2.6×	247	8.4k
Maryse Lapeyre‐Mestre France	46	1.3k 1.3×	1.2k 1.6×	730 1.1×	498 0.8×	868 1.5×	435	9.0k
Olav Spigset Norway	47	1.1k 1.0×	2.3k 2.9×	771 1.1×	342 0.6×	701 1.2×	366	8.4k
Denise M. Boudreau United States	41	839 0.8×	521 0.7×	564 0.8×	627 1.0×	1.1k 2.0×	125	6.2k
Jean‐Louis Montastruc France	51	1.0k 1.0×	1.1k 1.3×	1.1k 1.5×	430 0.7×	1.1k 1.9×	458	10.5k
Annie Fourrier‐Réglat France	31	799 0.8×	528 0.7×	504 0.7×	225 0.4×	303 0.5×	125	3.7k
Tara Gomes Canada	46	1.0k 1.0×	844 1.1×	1.6k 2.4×	597 1.0×	1.4k 2.4×	363	9.3k
Eibert R. Heerdink Netherlands	42	862 0.8×	1.7k 2.2×	1.3k 1.9×	261 0.4×	344 0.6×	236	6.5k
Devan Kansagara United States	37	726 0.7×	555 0.7×	1.1k 1.6×	277 0.5×	541 0.9×	134	7.7k

Countries citing papers authored by Yola Moride

Since Specialization

Citations

This map shows the geographic impact of Yola Moride's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yola Moride with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yola Moride more than expected).

Fields of papers citing papers by Yola Moride

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yola Moride. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yola Moride. The network helps show where Yola Moride may publish in the future.

Co-authorship network of co-authors of Yola Moride

This figure shows the co-authorship network connecting the top 25 collaborators of Yola Moride. A scholar is included among the top collaborators of Yola Moride based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yola Moride. Yola Moride is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moride, Yola, et al.. (2024). Where are the data to assess the safety of paternal drug exposure? A systematic review of secondary databases: A contribution from IMI concePTION. Pharmacoepidemiology and Drug Safety. 33(2). e5764–e5764. 2 indexed citations

Moride, Yola, Andrée Néron, Marc O. Martel, et al.. (2023). A Descriptive Analysis of Adverse Event Reports from the Quebec Cannabis Registry. Drug Safety. 47(2). 161–171. 1 indexed citations

Du, Ping, et al.. (2023). Von Willebrand Disease Epidemiology, Burden of Illness and Management: A Systematic Review. Journal of Blood Medicine. Volume 14. 189–208. 23 indexed citations

Bergamasco, Aurore, et al.. (2022). Epidemiology of Asymptomatic Pre-heart Failure: a Systematic Review. Current Heart Failure Reports. 19(3). 146–156. 10 indexed citations

Viganò, Antonio, Yola Moride, Marc O. Martel, et al.. (2022). The Quebec Cannabis Registry: Investigating the Safety and Effectiveness of Medical Cannabis. Cannabis and Cannabinoid Research. 8(6). 1106–1116. 8 indexed citations

Bergamasco, Aurore, et al.. (2016). Prevalence of gastroenteropancreatic and lung neuroendocrine tumours in the European Union. Annals of Oncology. 27. vi139–vi139. 1 indexed citations

Gage, Sophie Billioti de, Yola Moride, Thiérry Ducruet, et al.. (2014). Benzodiazepine use and risk of Alzheimer's disease: case-control study. BMJ. 349(sep09 2). g5205–g5205. 380 indexed citations breakdown →

Juurlink, David N., Colin R. Dormuth, Anjie Huang, et al.. (2013). Proton Pump Inhibitors and the Risk of Adverse Cardiac Events. PLoS ONE. 8(12). e84890–e84890. 30 indexed citations

Béland, Sarah‐Gabrielle, Marie Tournier, Guillaume Galbaud du Fort, et al.. (2011). Economic Impact of Nonpersistence with Antidepressant Treatment in the Adult Population of Quebec: A Comparative Cost-Effectiveness Approach. Value in Health. 14(4). 492–498. 13 indexed citations

10.

Béland, Sarah‐Gabrielle, Michel Préville, Marie‐France Dubois, et al.. (2010). Benzodiazepine use and quality of sleep in the community-dwelling elderly population. Aging & Mental Health. 14(7). 843–850. 41 indexed citations

11.

Chakra, Claire Nour Abou, et al.. (2010). Case Series in Drug Safety. Drug Safety. 33(12). 1081–1088. 6 indexed citations

12.

Fourrier‐Réglat, Annie, C. Droz‐Perroteau, Jacques Bénichou, et al.. (2008). Impact of Prescriber Nonresponse on Patient Representativeness. Epidemiology. 19(2). 186–190. 19 indexed citations

13.

Moride, Yola, et al.. (2005). Utilization of non-steroidal anti-inflammatory drugs in Quebec: adherence to the Canadian consensus on prescription guidelines.. PubMed. 12(2). e201–11. 6 indexed citations

14.

Moride, Yola. (2003). Persistency of use of COX-2-specific inhibitors and non-specific non-steroidal anti-inflammatory drugs (NSAIDs) in Quebec. British journal of rheumatology. 42(90003). 17iii–22. 18 indexed citations

15.

Rossignol, Michel, Yola Moride, Sylvie Perreault, et al.. (2002). Recommendations for the prevention of osteoporosis and fragility fractures. International comparison and synthesis.. PubMed. 18(3). 597–610. 7 indexed citations

16.

Wolfson, Christina, Mark Oremus, Vijay K. Shukla, et al.. (2002). Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness. Clinical Therapeutics. 24(6). 862–886. 48 indexed citations

17.

Egan, Mary, Christina Wolfson, Yola Moride, & Johanne Monette. (2000). Do patient factors alter the relationship between physician characteristics and use of long-acting benzodiazepines?. Journal of Clinical Epidemiology. 53(11). 1181–1187. 5 indexed citations

18.

Abenhaim, Lucien, Yola Moride, F Brénot, et al.. (1997). Appetite-suppressant drugs and the risk of primary pulmonary hypertension. Pneumologie. 51(10). 7 indexed citations

19.

Abenhaim, Lucien, Yola Moride, François Brenot, et al.. (1996). Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension. New England Journal of Medicine. 335(9). 609–616. 813 indexed citations breakdown →

20.

Moride, Yola & Joseph Hayes. (1993). Correlated responses in growth hormone to selection for weight gain in mice. Journal of Animal Breeding and Genetics. 110(1-6). 450–458. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact